{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:40:03Z","timestamp":1785523203483,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"DOI":"10.1007\/s00795-026-00471-5","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:28:48Z","timestamp":1785155328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EWSR1-SMAD3\u2013rearranged fibroblastic tumor: a case report with literature review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7725-1805","authenticated-orcid":false,"given":"Guanghong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baizhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"471_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/PAS.0000000000001002","volume":"42","author":"YC Kao","year":"2018","unstructured":"Kao YC, Flucke U, Eijkelenboom A, Zhang L, Sung YS, Suurmeijer AJH, Antonescu CR (2018) Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg Pathol 42:522\u2013528","journal-title":"Am J Surg Pathol"},{"key":"471_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00428-025-04394-x","volume":"488","author":"G Cazzato","year":"2026","unstructured":"Cazzato G, Fortarezza F, Daruish M, Annese T, Ribatti D, Ingravallo G, Mura MD, Sorino J, Tos APD, Giubellino A, Ricci C, Cabala CAT, Yang RK, Cho WC (2026) Gene fusion-driven cutaneous mesenchymal neoplasms: an updated review emphasizing the emerging entities. Virchows Arch 488:229\u2013244","journal-title":"Virchows Arch"},{"key":"471_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104291","volume":"110","author":"L Zhao","year":"2019","unstructured":"Zhao L, Sun M, Lao IW, Yu L, Wang J (2019) EWSR1-SMAD3 positive fibroblastic tumor. Exp Mol Pathol 110:104291","journal-title":"Exp Mol Pathol"},{"key":"471_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/PAS.0000000000001109","volume":"42","author":"M Michal","year":"2018","unstructured":"Michal M, Berry RS, Rubin BP, Kilpatrick SE, Agaimy A, Kazakov DV, Steiner P, Ptakova N, Martinek P, Hadravsky L, Michalova K, Szep Z, Michal M (2018) EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic\/myofibroblastic neoplasms. Am J Surg Pathol 42:1325\u20131333","journal-title":"Am J Surg Pathol"},{"key":"471_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cup.13870","volume":"48","author":"O Habeeb","year":"2021","unstructured":"Habeeb O, Korty KE, Azzato EM, Astbury C, Farkas DH, Ko JS, Billings SD (2021) EWSR1-SMAD3 rearranged fibroblastic tumor: case series and review. J Cutan Pathol 48:255\u2013262","journal-title":"J Cutan Pathol"},{"key":"471_CR6","doi-asserted-by":"publisher","first-page":"26494","DOI":"10.1073\/pnas.2015980117","volume":"117","author":"CM Schafer","year":"2020","unstructured":"Schafer CM, Gurley JM, Kurylowicz K, Lin PK, Chen W, Elliott MH, Davis GE, Bhatti F, Griffin CT (2020) An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression. Proc Natl Acad Sci U S A 117:26494\u201326502","journal-title":"Proc Natl Acad Sci U S A"},{"key":"471_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051118","volume":"14","author":"F Lorenzin","year":"2022","unstructured":"Lorenzin F, Demichelis F (2022) Past, current, and future strategies to target ERG fusion-positive prostate cancer. Cancers (Basel) 14:1118","journal-title":"Cancers (Basel)"},{"key":"471_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061093","volume":"11","author":"U Flucke","year":"2021","unstructured":"Flucke U, van Noesel MM, Siozopoulou V, Creytens D, Tops BBJ, van Gorp JM, Hiemcke-Jiwa LS (2021) EWSR1-the most common rearranged gene in soft tissue lesions, which also occurs in different bone lesions: an updated review. Diagnostics (Basel) 11:1093","journal-title":"Diagnostics (Basel)"},{"key":"471_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","volume":"29","author":"P ten Dijke","year":"2004","unstructured":"ten Dijke P, Hill CS (2004) New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29:265\u2013273","journal-title":"Trends Biochem Sci"},{"key":"471_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2005.09.008","volume":"17","author":"AB Roberts","year":"2006","unstructured":"Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC (2006) Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17:19\u201327","journal-title":"Cytokine Growth Factor Rev"},{"key":"471_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY (2018) New insights into TGF-beta\/Smad signaling in tissue fibrosis. Chem Biol Interact 292:76\u201383","journal-title":"Chem Biol Interact"},{"key":"471_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030326","volume":"17","author":"F Runa","year":"2024","unstructured":"Runa F, Ortiz-Soto G, de Barros NR, Kelber JA (2024) Targeting SMAD-dependent signaling: considerations in epithelial and mesenchymal solid tumors. Pharmaceuticals (Basel) 17:326","journal-title":"Pharmaceuticals (Basel)"},{"key":"471_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/1471-2407-11-507","volume":"11","author":"JC Brase","year":"2011","unstructured":"Brase JC, Johannes M, Mannsperger H, Falth M, Metzger J, Kacprzyk LA, Andrasiuk T, Gade S, Meister M, Sirma H, Sauter G, Simon R, Schlomm T, Beissbarth T, Korf U, Kuner R, Sultmann H (2011) TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling. BMC Cancer 11:507","journal-title":"BMC Cancer"},{"key":"471_CR14","first-page":"19","volume":"52","author":"HY Su","year":"2023","unstructured":"Su HY, Zhao L, Ji G, Yao QL, Bai QM, Zhou XY, Wang J (2023) EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis. Zhonghua Bing Li Xue Za Zhi 52:19\u201324","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"471_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1066896920938124","volume":"29","author":"O Foot","year":"2021","unstructured":"Foot O, Hallin M, Jones RL, Sumathi VP, Thway K (2021) EWSR1-SMAD3-positive fibroblastic tumor. Int J Surg Pathol 29:179\u2013181","journal-title":"Int J Surg Pathol"},{"key":"471_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00256-020-03563-0","volume":"50","author":"S De Noon","year":"2021","unstructured":"De Noon S, Flanagan AM, Tirabosco R, O\u2019Donnell P, Amary F (2021) EWSR1-SMAD3 fibroblastic tumour of bone: expanding the clinical spectrum. Skeletal Radiol 50:445\u2013450","journal-title":"Skeletal Radiol"},{"key":"471_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1017310","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Fan L, Yin Z, Liu Y, Zhao D, Wang Z, Cheng H (2022) EWSR1::SMAD3-rearranged fibroblastic tumor: a case with twice recurrence and literature review. Front Oncol 12:1017310","journal-title":"Front Oncol"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-026-00471-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:24:08Z","timestamp":1785518648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-026-00471-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":17,"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1007\/s00795-026-00471-5","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for this publication.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Fourth Affiliated Hospital, Zhejiang University School of Medicine (Approval No. k2025285).","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}